This collaboration allows physicians to order Myriad’s MyRisk Hereditary Cancer Test and view the results of the test directly in Flatiron’s cloud-based Electronic Medical Record (EMR ...

Storm will promote the MyRisk® with RiskScore® Hereditary Cancer Test, which evaluates genetic risks for various cancers. She emphasizes the significance of understanding family health history ...

which features the MyRisk with RiskScore Hereditary Cancer test. The latest collaboration with Storm will bolster the company’s Hereditary Cancer testing business. Myriad Genetic’s shares ...

which features the MyRisk with RiskScore Hereditary Cancer test. The latest collaboration with Storm will bolster the company’s Hereditary Cancer testing business. Myriad Genetic’s shares edged up 0.5 ...

Myriad Genetics faces a tough year ahead with new policy changes. Learn why MYGN stock has cratered and if it's poised for ...

SALT LAKE CITY, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced an agreement with Hannah Storm, a nationally ...

(MENAFN- GlobeNewsWire - Nasdaq) SALT LAKE CITY, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced an agreement ...

(RTTNews) - Myriad Genetics Inc. (MYGN) announced an agreement with Hannah Storm, a nationally renowned sports broadcaster, who recently revealed her battle with breast cancer. As per the deal ...